RxDoctor Payments Data

Jeanette Miller, APRN

Psychiatric/Mental Health · Houston, TXNPI 1316544810

Payments from drug & device makers

$1,521in general payments, 2019–2025

Across 85 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$407
  • Sunovion Pharmaceuticals Inc.$308
  • Johnson & Johnson$281
  • Takeda Pharmaceuticals U.S.A., Inc.$175
  • Teva Pharmaceuticals USA, Inc.$104
  • Alkermes, Inc.$67
  • plus $178 from 4 others

What the payments were for

  • Food & beverage$1,521100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,521 in reported general payments places this provider in the 70th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$17,469
Medicare patients
53
Services billed
214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl33$63,666
Lurasidone Hcl103$28,855
RexultiBrexpiprazole11$18,772
BelsomraSuvorexant42$18,132
Paliperidone ErPaliperidone41$15,190
TrintellixVortioxetine Hydrobromide19$11,777
Aripiprazole114$8,097
Oxcarbazepine126$7,288
Quetiapine Fumarate220$6,745
Clozapine41$6,446
Divalproex Sodium ErDivalproex Sodium73$4,480
Duloxetine Hcl163$4,193
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21$4,081
QelbreeViloxazine Hcl11$3,848
Trazodone Hcl271$2,986

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$407$63,66633 claims
Otsuka America Pharmaceutical, Inc.Rexulti$64$18,77211 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$175$11,77719 claims
Supernus Pharmaceuticals, Inc.Qelbree$24$3,84811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →